MYD88
L265P mutation and interleukin‐10 detection in cerebrospinal fluid are highly specific discriminating markers in patients with primary central nervous system lymphoma: results from a prospective study
2016 ◽
Vol 177
(3)
◽
pp. 492-494
◽
2019 ◽
Vol 60
(12)
◽
pp. 2880-2889
◽
1997 ◽
Vol 115
(9)
◽
pp. 1157
◽
2017 ◽
Vol 58
(10)
◽
pp. 2452-2459
◽